All Articles

Unraveling the complexity of drug resistance mechanisms to SINE, T cell-engaging therapies and CELMoDs in multiple myeloma: a comprehensive review

Inhibition of glutaminolysis alone and in combination with HDAC inhibitor has anti-myeloma therapeutic effects

Recent advanced lipid-based nanomedicines for overcoming cancer resistance

The evolving role of immune checkpoint inhibitors in cervical and endometrial cancer

Mechanisms of action and resistance to anti-HER2 antibody-drug conjugates in breast cancer

Validation of single nucleotide polymorphisms potentially related to R-CHOP resistance in diffuse large B-cell lymphoma patients

ALK inhibitors in cancer: mechanisms of resistance and therapeutic management strategies

Chemosensitizing effect of pentoxifylline in sensitive and multidrug-resistant non-small cell lung cancer cells

Advancing CAR T-cell therapy for chronic lymphocytic leukemia: exploring resistance mechanisms and the innovative strategies to overcome them

Current knowledge about immunotherapy resistance for melanoma and potential predictive and prognostic biomarkers

Isocucurbitacin B inhibits glioma growth through PI3K/AKT pathways and increases glioma sensitivity to TMZ by inhibiting hsa-mir-1286a

Emerging role of MYB transcription factors in cancer drug resistance

HER3-targeted therapy: the mechanism of drug resistance and the development of anticancer drugs

The therapeutic potential of circular RNA in triple-negative breast cancer

Mechanisms underlying reversed TRAIL sensitivity in acquired bortezomib-resistant non-small cell lung cancer cells

Dysregulation of calcium homeostasis in cancer and its role in chemoresistance

Overcoming immuno-resistance by rescheduling anti-VEGF/cytotoxics/anti-PD-1 combination in lung cancer model

Circular RNA circNCOA3 promotes tumor progression and anti-PD-1 resistance in colorectal cancer